Dong Ki Lee

This inventor holds 17 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in RNA Interference. Top assignees: Olix Pharmaceuticals, Inc., Korea Institute of Science and Technology, Sungkyunkwan University. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Ki Lee. Retrieved from https://idiyas.com/inventor/dong-ki-lee-8hwhf0x2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 17)

% Patents Active = 88.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 36(Granted Patents)

Location History:

Seoul, KR (2013 - 2023)
Gyeonggi-do, KR (2021 - 2023)

Company Filing History:

8 out of 16

Olix Pharmaceuticals, Inc.

patents

4 out of 2,251

Korea Institute of Science and Technology

patents

4 out of 1,366

Sungkyunkwan University

patents

4. 1 out of 2

Oncotag Diagnostics Co., Ltd.

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Carbon Dioxide Reduction

RNA Interference

Electrocatalysts

Nucleic Acid Molecules

Bile Duct Cancer

Pharmaceutical Compositions

Idiopathic Pulmonary Fibrosis

Angiogenesis

Atopic Dermatitis

Age-Related Macular Degeneration

RNA Complexes

SiRNA Structure

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577695 - System of utilizing carbon dioxide (2026-03-17),

2. 12480218 - Basic electrocatalyst for carbon dioxide reduction and ethylene production, electrode and apparatus each including the same, and method of manufacturing the electrode (2025-11-25),

3. 11813567 - Method of and device for removing nitrogen oxide in gas (2023-11-14),

4. 11591600 - Long double-stranded RNA for RNA interference (2023-02-28),

5. 11588157 - Iridium alloy catalyst having reversible catalytic activity and preparation method thereof (2023-02-21),

6. 11561222 - Method for diagnosis of bile duct cancer using methionyl-tRNA synthetase in bile duct cell (2023-01-24),

7. 11040057 - Pharmaceutical compositions and methods for potentiating gene silencing (2021-06-22),

8. 10829761 - Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor (2020-11-10),

9. 10829760 - Nucleic acid molecules inducing RNA interference, and uses thereof (2020-11-10),

10. 10519449 - Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB (2019-12-31),

11. 10358648 - Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1 (2019-07-23),

12. 10301628 - Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor (2019-05-28),

13. 10214744 - Nucleic acid molecules inducing RNA interference, and uses thereof (2019-02-26),

14. 10059949 - Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3 (2018-08-28),

15. 9637742 - Nucleic acid molecules inducing RNA interference, and uses thereof (2017-05-02),

Hello! How may I help you today in learning more about inventor Dong Ki Lee? Let's delve into the exciting world of his innovations and patents.

Title: Exploring the Innovations of Inventor Dong Ki Lee

Introduction: Dong Ki Lee is a prolific inventor based in Seoul, South Korea, known for his groundbreaking inventions and patents in various fields.

Latest Patents: Dong Ki Lee's latest patents showcase his ingenuity and expertise in developing cutting-edge technologies. One such patent is the "Method of and device for removing nitrogen oxide in gas," which revolutionizes the process of cleaning nitrogen oxide from gases. Additionally, his patent on "Long double-stranded RNA for RNA interference" highlights his contributions to gene expression inhibition.

Career Highlights: Throughout his career, Dong Ki Lee has amassed an impressive portfolio of 15 patents, demonstrating his dedication to innovation and problem-solving. His work reflects a deep understanding of complex scientific principles and a commitment to pushing the boundaries of technology.

Collaborations: Dong Ki Lee has collaborated with esteemed organizations such as Olix Pharmaceuticals, Inc. and Sungkyunkwan University Foundation for Corporate Collaboration. His partnerships with experts like Sun Woo Hong and Tae Yeon Lee have led to the development of groundbreaking technologies with real-world applications.

Conclusion: In conclusion, Dong Ki Lee's innovative spirit and passion for invention have solidified his reputation as a trailblazer in the field of patents and innovations. His contributions continue to inspire future generations of inventors to think outside the box and push the limits of what is possible.

I hope this overview of Dong Ki Lee's achievements has provided valuable insights into his remarkable career in the world of inventions and patents. If you have any more questions or need further information, feel free to ask!

Profile summary based on public USPTO records.